Clinical Trial

Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy

Study acronym: SwallPEG
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Open-label, interventional, multicentric, randomized, phase III study. Cancer studied is the oropharyngeal cancer. Study is composed by 2 arms of subjects: prophylactic or reactive percutaneous endoscopic gastrostomy tube placement. All subjects will be treated with a cisplatin standard chemotherapy regimen and by simultaneous integrated boost (SIB) intensity modulated radiotherapy (IMRT).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-07-12; most recent amendment 2023-05-09.
Status change: Not Yet Recruiting → Recruiting 2019-09-24
Trial Details
NCT Number NCT04019548
Lead Sponsor Jules Bordet Institute
Conditions Oropharyngeal Cancer
Enrollment 110 participants
Start Date 2019-12-16
Primary Completion 2027-11-01 (estimated)
Study Completion 2030-05-01 (estimated)
Updated on ClinicalTrials.gov 2023-05-10